{"record_key":"panther-life-sciences","identifier":"panther-life-sciences","external_key":null,"title":"Panther Life Sciences","summary":null,"url":"https://inventions.pitt.edu/startups/panther-life-sciences","json_url":"https://inventions.pitt.edu/startups/panther-life-sciences.json","object_key":"startups","description":"Panther Life Sciences is developing treatments delivered through dissolvable microarray patches (MAPs), which it calls the SmartPatch, as an alternative to needles, syringes, transdermals, pills, and syrups. The company does not develop new compounds; it engineers delivery of already proven treatments. [1]: https://www.pantherls.com/\nThe shelf-stable patch is designed for self-application and delivers precisely controlled doses to specific depths in the skin, with integrated treatment tracking. Target markets include clinical skincare, oncology, longevity and anti-aging, and dermal fillers. [1]: https://www.pantherls.com/\nPanther is commercializing technology licensed from the University of Pittsburgh and Carnegie Mellon University, and has a strategic alliance with Pitt BioForge to scale manufacturing of its patches. [2]: https://www.medicaldesignbriefs.com/component/content/article/52655-panther-life-sciences-partners-with-bioforge-to-accelerate-development-and-manufacturing-of-microarray-patches\nThe company was co-founded by Chairman Carlos Bhola and Anne Moon, and is led by CEO Mounir Hanana. [3]: https://www.pantherls.com/team.html","attributes":[{"key":"website","label":"Website","values":["https://www.pantherls.com"]},{"key":"sector","label":"Sector","values":["Therapeutics"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Dermatology","Oncology"]},{"key":"funding_stage","label":"Funding Stage","values":["Pre-Seed"]},{"key":"founders","label":"Founders","values":["Carlos Bhola","Anne Moon"]}],"related":[]}